Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 661-671

  Sabbe, R ^a   Picchio, G R ^a   Pastore, C ^a   Chaloin, O ^a   Hartley, O ^a   Offord, R ^a   Mosier, D E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ADULT; BLOOD DONORS; CD4-POSITIVE T-LYMPHOCYTES; GENOTYPE; HUMANS; LIGANDS; RANTES; RECEPTORS, CCR5;

EID: 0035172169     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.661-671.2001     Document Type: Article

References (67)

1. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor down-modulation
2. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5-Δ32
3. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
4. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains
5. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
6. The HIV coreceptors CXCR4 and CXCR5 are differentially expressed and regulated on human T lymphocytes
7. Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences
8. Novel alleles of the chemokine-receptor gene CCR5
9. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
10. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
11. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
12. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
13. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
14. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
15. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
16. Identification of a major co-receptor for primary isolates of HIV-1
17. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
18. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC·CKR-5
19. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
20. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
21. Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors implications for HIV-1 coreceptor function
22. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
23. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
24. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
25. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection
26. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
27. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants
28. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4
29. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
30. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
31. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function
32. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
33. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function
34. Genetic acceleration of AIDS progression by a promoter variant of CCR5
35. CCR5 promoter polymorphism and HIV-1 disease progression
36. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
37. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32
38. Highly Potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
39. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
40. Evolution of human and nonhuman primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorpic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus
41. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
42. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
43. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells
44. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression
45. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
46. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice
47. The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins
48. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1
49. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
50. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
51. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry
52. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells
53. ChemR23, a putative chemoattractant receptor, is expresed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains
54. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
55. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells
56. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses
57. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
58. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
59. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study
60. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1
61. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants
62. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
63. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex
64. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES
65. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
66. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5